Q1 2027 Archean Chemical Industries Ltd Earnings Call Transcript
Key Points
- Highest quarterly revenue in the last five quarters, with revenue up 14% year-on-year and 9% sequentially.
- Bromine volumes hit a five-quarter high with realizations up 50% year-on-year, and the company expects to maintain firm pricing around INR300 per kg.
- Accum Chemicals, the derivatives business, turned EBITDA positive for the first time, with revenue up 28% year-on-year.
- Sulphate of potash (SOP) Phase 1 trials were successfully completed, with Phase 2 trials expected by end of Q3 FY27, supporting the path to commercial production.
- Brinefield expansion Phase 1 is mostly complete, with commissioning potentially preponed to post-monsoon, and land lease extension discussions are progressing positively.
- EBITDA margin expanded sequentially from 21.8% in Q4 FY26 to 25.3% in Q1 FY27, with profit after tax up 36% sequentially.
- Industrial salt volumes declined 12% year-on-year due to logistics issues, vessel shortages, and order deferments from the West Asia conflict.
- Logistics and transportation costs increased significantly, with road haul distances up 50% and diesel prices up 40-50% year-on-year, impacting profitability.
- Sea freight costs increased by 30-35%, raising landed costs for customers in East and South Asia.
- Bromine production was impacted by grid power shortages and planned shutdowns, resulting in a shortfall of about 325 tons versus the targeted run rate.
- Consolidated performance was affected by scaling costs of the semiconductor business, with EBITDA loss of $13.4 million in the oilfield chemicals segment.
- SOP feedstock costs remain a near-term challenge, with higher sulfate process prices impacting profitability.
Ladies and Gentlemen, Good Day and Welcome Q1 SY27 earnings conference call of Arkane Chemicals Industries Ltd. This conference call may contain forward-looking statements about the company which are based on the beliefs, opinions and expectations of the company as on date of this call. These statements are not the guarantees of future performance and involve risk and certainties that are difficult to predict.
(Operator Instructions) Please note that this conference is being recorded. And now in the conference, over to Mr. Rampraveen Swaminathan, Managing Director. Thank you and over to you, sir.
Good morning, everyone, and a warm welcome to our Q1 FY27 earnings call. Thank you for taking the time to join us today, and I hope you all are safe, especially those of you who are in weather affected regions.
On this call today, I'm joined by Mr. R. Natarajan, our CFO; Mr. Rajeev Kumar, DGM Finance and Strategy, members of our finance team, and SGI Investor Relations
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
